From Casetext: Smarter Legal Research

Kobylinski v. Merck & Co. (In re Zostavax (Zoster Vaccine Live) Prods. Liab. Litig.)

United States District Court, E.D. Pennsylvania
Oct 4, 2023
MDL 2848 (E.D. Pa. Oct. 4, 2023)

Opinion

MDL 2848 CIVIL ACTION 19-4772

10-04-2023

IN RE ZOSTAVAX (ZOSTER VACCINE LIVE) PRODUCTS LIABILITY LITIGATION v. MERCK & CO., INC., et al. THIS DOCUMENT RELATES TO KAY KOBYLINSKI & THOMAS EUGENE KOBYLINSKI


PRETRIAL ORDER NO. 507

Harvey Bartle III Judge

AND NOW, this 4th day of October 2023, for the reasons set forth in the foregoing Memorandum, it is hereby ORDERED that the motion of defendants Merck & Co., Inc. and Merck Sharp & Dohme Corp. to exclude the causation opinions of Joseph Jeret, M.D. (MDL Doc. # 1234) is GRANTED.


Summaries of

Kobylinski v. Merck & Co. (In re Zostavax (Zoster Vaccine Live) Prods. Liab. Litig.)

United States District Court, E.D. Pennsylvania
Oct 4, 2023
MDL 2848 (E.D. Pa. Oct. 4, 2023)
Case details for

Kobylinski v. Merck & Co. (In re Zostavax (Zoster Vaccine Live) Prods. Liab. Litig.)

Case Details

Full title:IN RE ZOSTAVAX (ZOSTER VACCINE LIVE) PRODUCTS LIABILITY LITIGATION v…

Court:United States District Court, E.D. Pennsylvania

Date published: Oct 4, 2023

Citations

MDL 2848 (E.D. Pa. Oct. 4, 2023)